It looks as though Phillip Robinson may achieve something most researchers don't dare to dream of- seeing his past decades' bench slog translate into a commercially available drug to treat conditions such as epilepsy. It's early days, but companies are already contacting the neuro-biologist, declaring their interest in taking his products into the clinic.
展开▼
